{{Rsnum
|rsid=319217
|Gene=PPP2R2B
|Chromosome=5
|position=146874330
|Orientation=plus
|GMAF=0.4619
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=PPP2R2B
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 52.3 | 36.9 | 10.8
| HCB | 6.7 | 40.0 | 53.3
| JPT | 11.4 | 47.7 | 40.9
| YRI | 9.5 | 19.0 | 71.4
| ASW | 0.0 | 0.0 | 0.0
| CHB | 6.7 | 40.0 | 53.3
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=20669227
|Title=A genetic variant in a PP2A regulatory subunit encoded by the PPP2R2B gene associates with altered breast cancer risk and recurrence
|OA=1
}}

{{PMID|21226949|OA=1
}} Co-regulatory expression quantitative trait loci mapping: method and application to endometrial cancer.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}